Heron Therapeutics

Health Care  |  Biotechnology
3.36 0.18 5.66%
Stock Price | May 27, 2022, 4 p.m.
Bid: 3.02
Ask: 18.48
Prev. Close: 3.18
52 Week Low: 3.05
52 Week High: 16.63
PE Ratio:
Dividend Yield: %

Company Summary

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Read more Read less

Recently Viewed Tickers